APPLICATION
BLA021484
TYPE
BLA
ORIGINAL APPROVAL
2002-12-19
LATEST ACTION
2002-12-19
ROUTE
Subcutaneous
DOSAGE FORM
Injectable
MARKETING STATUS
Prescription
Products
BRAVELLEPrescription
UROFOLLITROPIN 0.9% · Injectable · Subcutaneous
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.